These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32580051)

  • 1. 3D projection and multivariate image analysis for quantitative visual modelling of mixability and rheological behavior of lactose powder.
    Lee WB; Widjaja E; Heng PWS; Chan LW
    Eur J Pharm Biopharm; 2020 Aug; 153():241-256. PubMed ID: 32580051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of rotation speed and particle size distribution variability on mixability: An avalanche rheological and multivariate image analytical approach.
    Lee WB; Widjaja E; Heng PWS; Chan LW
    Int J Pharm; 2020 Apr; 579():119128. PubMed ID: 32044403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the effect and mechanism of particle size distribution variability on mixing using avalanche testing and multivariate modelling.
    Lee WB; Widjaja E; Heng PWS; Chan LW
    Int J Pharm; 2019 May; 563():9-20. PubMed ID: 30904727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near infrared spectroscopy for rapid and in-line detection of particle size distribution variability in lactose during mixing.
    Lee WB; Widjaja E; Heng PWS; Chan LW
    Int J Pharm; 2019 Jul; 566():454-462. PubMed ID: 31170478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-risking excipient particle size distribution variability with automated robust mixing: Integrating quality by design and process analytical technology.
    Lee WB; Widjaja E; Heng PWS; Chan LW
    Eur J Pharm Biopharm; 2020 Dec; 157():9-24. PubMed ID: 33022392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation and functionality of inhalation anhydrous lactose.
    Pitchayajittipong C; Price R; Shur J; Kaerger JS; Edge S
    Int J Pharm; 2010 May; 390(2):134-41. PubMed ID: 20100552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.
    Stranzinger S; Faulhammer E; Calzolari V; Biserni S; Dreu R; Šibanc R; Paudel A; Khinast JG
    Int J Pharm; 2017 Jan; 516(1-2):9-20. PubMed ID: 27826028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F; Lejeune M; Edge S
    Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a dual approach to assess powder flow from avalanching behavior.
    Lee YS; Poynter R; Podczeck F; Newton JM
    AAPS PharmSciTech; 2000 Jul; 1(3):E21. PubMed ID: 14727907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powder dispersion mechanisms within a dry powder inhaler using microscale particle image velocimetry.
    Kou X; Wereley ST; Heng PW; Chan LW; Carvajal MT
    Int J Pharm; 2016 Dec; 514(2):445-455. PubMed ID: 27497998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flowability characterisation of drug-excipient blends using a novel powder avalanching method.
    Nalluri VR; Kuentz M
    Eur J Pharm Biopharm; 2010 Feb; 74(2):388-96. PubMed ID: 19796683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of powder flow parameters with reference to particle size and shape.
    Goh HP; Heng PWS; Liew CV
    Int J Pharm; 2018 Aug; 547(1-2):133-141. PubMed ID: 29803793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.
    Zhou Q; Armstrong B; Larson I; Stewart PJ; Morton DA
    J Pharm Sci; 2010 Feb; 99(2):969-81. PubMed ID: 19795479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Particle Surface Roughness on In-Die Flow and Tableting Behavior of Lactose.
    Tay JYS; Kok BWT; Liew CV; Heng PWS
    J Pharm Sci; 2019 Sep; 108(9):3011-3019. PubMed ID: 31054886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a micro dosing system for fine powder using a vibrating capillary. Part 1: the investigation of factors influencing on the dosing performance.
    Chen X; Seyfang K; Steckel H
    Int J Pharm; 2012 Aug; 433(1-2):34-41. PubMed ID: 22595639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New methods characterizing avalanche behavior to determine powder flow.
    Lavoie F; Cartilier L; Thibert R
    Pharm Res; 2002 Jun; 19(6):887-93. PubMed ID: 12134962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of α-lactose monohydrate as a direct compression excipient using roller compaction.
    Abu Fara D; Rashid I; Alkhamis K; Al-Omari M; Chowdhry BZ; Badwan A
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2038-2047. PubMed ID: 30095020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking flowability and granulometry of lactose powders.
    Boschini F; Delaval V; Traina K; Vandewalle N; Lumay G
    Int J Pharm; 2015 Oct; 494(1):312-20. PubMed ID: 26283279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.